Dual inhibition of ras and bcr-abl signalling pathways in chronic myeloid leukaemia: a phase I/II study in patients in complete haematological remission.

Source:http://linkedlifedata.com/resource/pubmed/id/17428238

Download in:

View as

General Info

PMID
17428238